# Weight Loss Peptides Philippines 2026: GLP-1 Source: https://www.philippinespeptides.com/weightloss Updated: 2026-10-01 > Retatrutide, tirzepatide, semaglutide and cagrilintide compared on trial results, FDA status and Philippine availability. On this page - [Comparison table](#compare) - [How the trials compare](#choose) - [The four options](#options) - [Branded and research-grade](#sourcing) - [Before buying](#start) 2026 Decision Hub # Weight loss peptides in the Philippines Philippines Peptides editorial desk Updated 1 October 2026 6 min read **Hub** - GLP-1 Decision **Compounds** - 04 Video guide: GLP-1 Medicines in the Philippines, Explained (2:12) New to GLP-1s in the Philippines? Here is what they are, what is registered, and the three ways to get them. GLP-1 is a hormone released after you eat. These medicines mimic it: more fullness, more insulin, slower digestion. Semaglutide acts on one receptor, tirzepatide on two, and retatrutide on three. Retatrutide is still investigational. In phase 3 trials, top-arm mean weight loss was 14.9% in STEP 1, 20.9% in SURMOUNT-1, and 28.3% in TRIUMPH-1. Ozempic, Wegovy, Mounjaro and Rybelsus are registered with FDA Philippines as prescription medicines. Prescribing belongs with a licensed Philippine physician. Route one, a pharmacy. At Watsons, an Ozempic 1 mg pen is ₱9,280. Mounjaro pens reach ₱29,900. Route two, telehealth, after a doctor's review. GoRocky lists from ₱3,990 a month. &you, ₱599 a month after a free first month, plus medication. Route three, research vials. Not the same product: a pen is a registered prescription medicine. A research vial is not approved for human use and is sold for research only. Our partner and supplier, Primara Labs, lists 15 mg vials: semaglutide, ₱1,990. Tirzepatide, ₱1,890. Retatrutide, [₱3,390 for the 20 mg vial]. Per mg, the Ozempic pen is about ₱2,320. The semaglutide research vial works out at ₱133 per mg, or ₱81 in a 10 pack. Not the same product. Every order includes bacteriostatic water, syringes and alcohol pads. Same day in Metro Manila before noon, J&T nationwide, and a 60-day money-back guarantee. Read the full GLP-1 guide on Philippines Peptides, then see the research vials at Primara Labs and order on WhatsApp. [Figures in square brackets corrected on 3 November 2026 from Primara's current catalogue: the narration gives the price of the 15 mg retatrutide vial, retired on 12 October 2026.] **TRIUMPH-1 mean weight lossPhase 3, 12 mg arm, 80 wk** - 28.3% **Compounds** - 04 GLP-1 head-to-head ## Comparison table GLP-1 / Multi-agonist peptides: PH 2026 | Compound | Mean weight loss, largest arm | FDA | PH Pharmacy | | --- | --- | --- | --- | | [Retatrutide](https://www.philippinespeptides.com/peptides/retatrutide) | 28.3% on 12 mg, TRIUMPH-1 (phase 3, 80 wk) | Phase 3 | Not available | | [Tirzepatide](https://www.philippinespeptides.com/peptides/tirzepatide) | 20.9% on 15 mg, SURMOUNT-1 (phase 3, 72 wk) | FDA | Registered as Mounjaro, prescription only | | [Semaglutide](https://www.philippinespeptides.com/peptides/semaglutide) | 14.9% on 2.4 mg, STEP 1 (phase 3, 68 wk) | FDA | Registered as Ozempic and Wegovy, prescription only | | [Cagrilintide](https://www.philippinespeptides.com/peptides/cagrilintide) | No trial figure on file | Phase 3 | Not available | Figures are mean body-weight change in each compound's pivotal trial, read from the synced trials dataset. Side effects from the same trials are on each compound page. Our partner and supplier Research vials: cost per mg | Product | Price | Per mg | | --- | --- | --- | | Primara Labs Retatrutide 20mg research vial20 mg per vial | ₱3,390₱2,076 each in a 10-pack | ₱170₱104 in a 10-pack | | Primara Labs Tirzepatide 15mg research vial15 mg per vial | ₱1,890₱1,155 each in a 10-pack | ₱126₱77 in a 10-pack | | Primara Labs Semaglutide 15mg research vial15 mg per vial | ₱1,990₱1,216 each in a 10-pack | ₱133₱81 in a 10-pack | Research vials are not approved for human use, are sold for research only, and must be reconstituted. - Stocked in Metro Manila; same-day delivery there for orders before 12 noon - Lab report: Janoshik, batch RETA-4728-A, retatrutide, bacterial endotoxin only; not identity or purity. Key [H2KI86I8GWB4](https://verify.janoshik.com/tests/234146_H2KI86I8GWB4), [batch reports](https://www.primaralabs.com/coa?utm_source=philippinespeptides&utm_medium=referral&utm_campaign=bridge&utm_content=weightloss) - [60-day money-back guarantee](https://www.primaralabs.com/guarantee?utm_source=philippinespeptides&utm_medium=referral&utm_campaign=bridge&utm_content=weightloss) - GCash, Maya, QR Ph bank transfer, InstaPay Primara Labs is our partner and supplier. ## How the three trial programmes compare **Retatrutide** is a triple agonist (GLP-1, GIP and glucagon receptors) developed by Eli Lilly. It is investigational and approved nowhere. In TRIUMPH-1, an 80-week phase 3 trial of 2,339 adults with obesity, or overweight with at least one weight-related condition, without diabetes, body weight fell by 19%, 25.9% and 28.3% on the 4 mg, 9 mg and 12 mg arms, against 2.2% on placebo. [Source](https://investor.lilly.com/news-releases/news-release-details/lillys-triple-agonist-retatrutide-delivered-powerful-weight-loss) The [retatrutide guide](https://www.philippinespeptides.com/peptides/retatrutide) lists its side effects from the same trials and its regulatory status, and the [retatrutide Philippines 2026 guide](https://www.philippinespeptides.com/guides/retatrutide-philippines-2026) covers the Philippine picture. **Semaglutide** is a GLP-1 receptor agonist developed by Novo Nordisk, the active ingredient in Ozempic (approved by the US FDA for type 2 diabetes in 2017) and Wegovy (approved for weight management in 2021). In STEP 1, a 68-week phase 3 trial of 1,961 adults with BMI of 30 or greater (27 or greater with at least one weight-related coexisting condition), without diabetes, body weight fell by 14.9% on the 2.4 mg arm, against 2.4% on placebo. [Source](https://doi.org/10.1056/NEJMoa2032183) Start with the [semaglutide Philippines 2026 guide](https://www.philippinespeptides.com/peptides/semaglutide). **Tirzepatide** is a dual agonist (GLP-1 and GIP receptors) developed by Eli Lilly, the active ingredient in Mounjaro and Zepbound. In SURMOUNT-1, a 72-week phase 3 trial of 2,539 adults with BMI of 30 or more, or 27 or more with at least one weight-related complication, excluding diabetes, body weight fell by 15%, 19.5% and 20.9% on the 5 mg, 10 mg and 15 mg arms, against 3.1% on placebo. [Source](https://doi.org/10.1056/NEJMoa2206038) Read the [tirzepatide Philippines 2026 guide](https://www.philippinespeptides.com/guides/tirzepatide-philippines-2026). These trials enrolled different populations over different lengths of time, so the figures are not a head-to-head comparison. Each compound page places the adverse events from the same trials next to the outcomes. ## The four options explained Triple-agonist ### Retatrutide [Retatrutide](https://www.philippinespeptides.com/peptides/retatrutide) is a triple-agonist peptide that activates GLP-1, GIP, and glucagon receptors. In TRIUMPH-1, a phase 3 trial, the 12 mg arm lost 28.3% of body weight on average at 80 weeks. In the Philippines, retatrutide isn't available at any pharmacy or hospital. The [retatrutide Philippines 2026 guide](https://www.philippinespeptides.com/guides/retatrutide-philippines-2026) covers COA red flags and legal status. Dual-agonist ### Tirzepatide [Tirzepatide](https://www.philippinespeptides.com/peptides/tirzepatide) is a dual-agonist peptide that activates both GLP-1 and GIP receptors. In SURMOUNT-1, a phase 3 trial, the 15 mg arm lost 20.9% of body weight on average at 72 weeks. Mounjaro registration and dated pharmacy prices are on the [Mounjaro page](https://www.philippinespeptides.com/guides/mounjaro-philippines). See the [tirzepatide Philippines 2026 guide](https://www.philippinespeptides.com/guides/tirzepatide-philippines-2026) or the focused [tirzepatide weight loss page](https://www.philippinespeptides.com/weightloss/tirzepatide). GLP-1 single-agonist ### Semaglutide [Semaglutide](https://www.philippinespeptides.com/peptides/semaglutide) is a GLP-1 receptor agonist, FDA-approved as Ozempic (diabetes) and Wegovy (obesity). In STEP 1, a phase 3 trial, the 2.4 mg arm lost 14.9% of body weight on average at 68 weeks. See the [semaglutide Philippines 2026 guide](https://www.philippinespeptides.com/peptides/semaglutide) or the focused [semaglutide weight loss page](https://www.philippinespeptides.com/weightloss/semaglutide). Amylin analogue ### Cagrilintide [Cagrilintide](https://www.philippinespeptides.com/peptides/cagrilintide) is an amylin analogue that works through a different mechanism than GLP-1 agonists. Amylin slows gastric emptying and signals satiety via different brain pathways than GLP-1. Novo Nordisk is testing cagrilintide combined with semaglutide in phase 3. The trials dataset this site draws on holds no cagrilintide result, so this page states no figure for it. ## Branded medicines and research-grade peptides Ozempic, Wegovy and Mounjaro are prescription medicines. Registration numbers and dated pharmacy prices are on the [GLP-1 price tracker](https://www.philippinespeptides.com/prices). Prescription only; prescribing belongs with a licensed Philippine physician. Trials and side effects: the [tirzepatide guide](https://www.philippinespeptides.com/peptides/tirzepatide). The law: [regulation hub](https://www.philippinespeptides.com/legal). Research-grade peptides are a separate category: research materials, not pharmacy products, and not a substitute for a prescribed medicine. The [supplier checklist](https://www.philippinespeptides.com/supply) sets out what to ask a seller before paying, and the [buying peptides in the Philippines guide](https://www.philippinespeptides.com/guides/buy-peptides-philippines) covers the rules on personal import. A proper COA comes from a third-party lab independent of the seller, shows HPLC purity testing with a clear chromatogram, lists actual peptide content in milligrams, and includes the specific batch number that matches your vial. The [COA verification guide](https://www.philippinespeptides.com/coa) explains how to read HPLC chromatograms and spot fake certificates. ## Before buying anything Work through the [supplier checklist](https://www.philippinespeptides.com/supply) and the [COA guide](https://www.philippinespeptides.com/coa), and read the compound page for what its trials found and the side effects they reported. Anything you intend to use belongs in a conversation with a licensed Philippine physician first. Retatrutide 20mg research vial ₱3,390, Tirzepatide 15mg research vial ₱1,890, Semaglutide 15mg research vial ₱1,990: from Primara Labs, our partner and supplier, stocked in Metro Manila. Research use only. --- Philippines Peptides sells nothing. Primara Labs is our partner and supplier. This is general information, not medical or legal advice.